Prognostic and therapeutic implication of m6A methylation in Crohn disease

N6-methyladenosine (m6A) methylation has been reported to participate in inflammatory bowel disease (including Crohn disease [CD]). However, the prognostic and therapeutic implication of m6A methylation modification in CD is still unclear. METHODS: Genomic information of CD patients was integrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yujin, Hu, Yonghui, Yuan, Mei, Xu, Weiwei, Du, Yaqin, Liu, Jinguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794314/
https://www.ncbi.nlm.nih.gov/pubmed/36595818
http://dx.doi.org/10.1097/MD.0000000000032399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794314/
https://www.ncbi.nlm.nih.gov/pubmed/36595818
http://dx.doi.org/10.1097/MD.0000000000032399

Ejemplares similares